TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

By

TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal Officer

By

TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

By

TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

By

TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit

By

TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

By

TScan Therapeutics Adds to Executive Leadership Team and Board of Directors

By

TScan Therapeutics Appoints Katina Dorton, J.D., M.B.A., to Its Board of Directors

By

TScan Therapeutics Strengthens Leadership Team with the Appointment of Brian M. Silver as Chief Financial Officer

By

TScan Therapeutics Announces $100 Million Series C Financing

By